Production (Stage)
Marker Therapeutics, Inc.
MRKR
$1.77
$0.2516.45%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 13.69M | 19.19M | 9.00M | 7.80M | 11.32M |
| Total Receivables | 2.46M | 2.35M | 744.40K | 2.49M | 1.85M |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 841.30K | 483.70K | 1.17M | 1.38M | 917.00K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 16.99M | 22.02M | 10.91M | 11.68M | 14.09M |
|
|
|||||
| Total Current Assets | 16.99M | 22.02M | 10.91M | 11.68M | 14.09M |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 16.99M | 22.02M | 10.91M | 11.68M | 14.09M |
|
|
|||||
| Total Accounts Payable | 1.30M | 1.07M | 1.90M | 1.08M | 1.20M |
| Total Accrued Expenses | 1.00M | 2.19M | 1.35M | 395.00K | 545.00K |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | 204.00K | 205.00K | 203.30K | 495.20K | 557.00K |
| Total Other Current Liabilities | 204.00K | 205.00K | 203.30K | 495.20K | 557.00K |
| Total Current Liabilities | 2.50M | 3.46M | 3.46M | 1.97M | 2.30M |
|
|
|||||
| Total Current Liabilities | 2.50M | 3.46M | 3.46M | 1.97M | 2.30M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 2.50M | 3.46M | 3.46M | 1.97M | 2.30M |
|
|
|||||
| Common Stock & APIC | 465.96M | 465.58M | 450.63M | 450.57M | 450.47M |
| Retained Earnings | -451.46M | -447.02M | -443.18M | -440.87M | -438.68M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 14.49M | 18.56M | 7.45M | 9.70M | 11.79M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 14.49M | 18.56M | 7.45M | 9.70M | 11.79M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 14.49M | 18.56M | 7.45M | 9.70M | 11.79M |
|
|
|||||